Tiskatel CA 40/5/12.5 Tablet 10's

Tiskatel CA 40/5/12.5 Tablet is an anti-hypertensive drug primarily used to treat high blood pressure (hypertension). Hypertension is a medical condition in which blood pressure is elevated persistently in the arteries. It is considered an essential risk factor for cardiovascular diseases. 

Tiskatel CA 40/5/12.5 Tablet consists of three anti-hypertensive medicines, Amlodipine, Chlorthalidone, and Telmisartan. Amlodipine belongs to the class of calcium channel blockers. It is a vasodilator that dilates (widens) blood vessels and increases blood flow, further improving the oxygen delivery to the heart tissue. Chlorthalidone belongs to the class of diuretics (water pills) with antihypertensive activity. It inhibits sodium and chloride reabsorption from absorbing excess salts that cause fluid retention or build-up. Chlorthalidone lowers blood pressure by decreasing the amount of blood the heart pumps (cardiac output) and reducing plasma and extracellular fluid volume (body fluids outside the cells). Telmisartan belongs to a group of drugs called angiotensin II receptor antagonists (angiotensin is a hormone that constricts blood vessels and increases blood pressure). It lowers blood pressure and increases blood flow by preventing the narrowing of blood vessels. 

In some cases, Tiskatel CA 40/5/12.5 Tablet can cause side effects like sleepiness, taste changes, ankle swelling, headache, flushing (feeling warmth in the face, ears, neck, and trunk), dizziness, tiredness, palpitations (irregular heartbeat), and upset stomach. Most of these side effects of Tiskatel CA 40/5/12.5 Tablet do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.

If you are known to be allergic to Tiskatel CA 40/5/12.5 Tablet or any other medicines, please inform your doctor. Before taking Tiskatel CA 40/5/12.5 Tablet , let your doctor know if you have any heart, kidney, or liver problems, diabetes, electrolyte imbalance, and dehydration. Avoid potassium supplements with Tiskatel CA 40/5/12.5 Tablet as it may lead to high potassium levels in the blood. Pregnant or breastfeeding women should also consult their doctor before taking Tiskatel CA 40/5/12.5 Tablet . It is advised to complete the prescribed course, even if you feel better. Please do not stop taking Tiskatel CA 40/5/12.5 Tablet on your own, as it may lead to the recurrence of symptoms or worsen the disease. Do not consume alcohol with Tiskatel CA 40/5/12.5 Tablet as it may increase the risk of low blood pressure.

Tiskatel CA 40/5/12.5 Tablet is an anti-hypertensive drug that treats high blood pressure (hypertension). It contains Amlodipine, Chlorthalidone, and Telmisartan. Amlodipine is a calcium channel blocker that dilates (widens) blood vessels and increases blood flow. It is used to treat high blood pressure, chest pain (angina), and other conditions caused by coronary artery disease. Chlorthalidone is a diuretic (water pill). It prevents the body from absorbing excess salts that cause fluid retention or build-up. It effectively treats high blood pressure, fluid retention in patients with congestive heart failure, cirrhosis (chronic damage) of the liver, kidney disorders, or edema caused by steroids or estrogen therapy. Telmisartan is an angiotensin II receptor antagonist (angiotensin is a hormone that constricts blood vessels and increases blood pressure). It lowers blood pressure and increases blood flow by preventing the narrowing of blood vessels. It reduces the risk of stroke, heart attack, or death from heart problems.

Monitor your blood pressure levels regularly. If you are known to be allergic to Tiskatel CA 40/5/12.5 Tablet or have any kidney or liver problems or severe dehydration, please inform your doctor beforehand. Brief your medical history if you have low blood pressure, diabetes, gout, lupus (immune system disorder), hyperkalemia (high potassium levels), heart diseases (aortic stenosis, heart failure), angioedema (swelling of the lower layer of skin and tissue), anuria (low or no urine output), and asthma before starting Tiskatel CA 40/5/12.5 Tablet . Avoid potassium supplements with Tiskatel CA 40/5/12.5 Tablet as it may lead to high potassium levels in the blood. Too much sweating, diarrhea, or vomiting while using Tiskatel CA 40/5/12.5 Tablet may lead to dehydration; hence it is advised to drink enough fluids. Tiskatel CA 40/5/12.5 Tablet can affect and harm the developing baby during pregnancy. Consult your doctor before using Tiskatel CA 40/5/12.5 Tablet if you are a pregnant or breastfeeding mother. Complete the course strictly as suggested by the doctor, even if you feel better, to avoid disease recurrence. Avoid consumption of alcohol with Tiskatel CA 40/5/12.5 Tablet as it may increase the risk of low blood pressure. Safety and effectiveness of Tiskatel CA 40/5/12.5 Tablet in pediatric patients have not been established.